Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read moreNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Veterinary Rehabilitation During and After Cancer Care
Veterinary rehabilitation uses a medically supervised assessment and individualized plan to address pain, weakness, mobility limits, deconditioning, and functional goals. In oncology it must be coordinated with the…
Read more
Mirtazapine for Appetite Support: Nausea-First and Interaction Boundary
Mirtazapine may support appetite in selected dogs or cats, but nausea, pain, obstruction, oral disease, diet, organ function, and serotonergic interactions need attention first.
Read moreCapromorelin for Appetite Support: Cause, Species, and Monitoring
Capromorelin is a ghrelin-receptor agonist used in species- and product-specific veterinary appetite settings; it does not replace evaluation of why intake fell.
Read more
Oral Mucositis and Mouth-Pain Support During Cancer Treatment
Painful oral inflammation or ulceration can interfere with eating, drinking, grooming, and medication and requires examination of treatment effects, infection, tumor, dental disease, and trauma.
Read more
Nutrition Screening From Cancer Diagnosis Through Follow-Up
Routine nutrition screening identifies intake, weight, muscle, diet, gastrointestinal, and feeding barriers early enough to act before severe loss develops.
Read moreComplete-and-Balanced Diets: Reading the Nutritional Adequacy Statement
A nutritional adequacy statement helps distinguish a sole diet from a treat, topper, or supplement, but palatability and patient-specific suitability still matter.
Read moreThe “Cancer Diet” Question: Evidence Without Universal Rules
There is no single diet proven appropriate for every dog or cat with cancer; intake, balance, tumor, treatment, comorbidities, and patient preference lead the decision.
Read moreHome-Prepared Diets: Veterinary Nutrition Formulation and Follow-Through
A home-prepared diet can meet selected patient needs only when a veterinary nutrition specialist formulates it and the household follows and updates the recipe accurately.
Read moreRaw Diets During Oncology Care: Patient and Household Infection Risk
Raw diets add microbial risk to an oncology household and are not recommended by current AAHA oncology guidance for immunocompromised patients.
Read more